Vivos Therapeutics, Inc. (NASDAQ:VVOS) Q4 2024 Earnings Conference Call March 31, 2025 5:00 PM ET
Company Participants
Bradford Amman – CFO, Treasurer & Secretary
Kirk Huntsman – Co-Founder, Chairman & CEO
Conference Call Participants
Guyn Kim – Water Tower Research
Scott Henry – Alliance Global Partners
Lucas Ward – Ascendiant Capital Markets
Operator
Good day, everyone, and welcome to the Vivos Therapeutics Full Year 2024 Earnings Conference Call. [Operator Instructions] This conference call is being recorded, and a replay of today’s call will be available on the Investor Relations section of Vivos’ website and will remain posted there for the next 30 days. I will now hand the call over to Brad Ammon, Vivos’ Chief Financial Officer, for introductions and the reading of the safe harbor statement. Please go ahead, Brad.
Bradford Amman
Thank you, Jenny. Hello, everyone, and welcome to our 2024 earnings conference call. A copy of our earnings press release is available on the Investor Relations section of our website at www.vivos.com. With us on today’s call are myself and Kirk Huntsman, Vivos’ Chairman and Chief Executive Officer. Today, we will review positive highlights and financial results for the full year 2024 as well as key recent developments in our marketing and distribution strategy pivot. Following these formal remarks, we will be happy to take questions. I would also like to remind everyone that today’s call will contain forward-looking statements from our management made within the meaning of Section 27A of the Securities Act of 1933 as amended and Section 21E of the Securities and Exchange Act of 1934 as amended concerning future events. Words such as aim, may, could, should, projects, expects, intends, plans, believes, anticipates, hopes, estimates, goal and variations of such words and similar expressions are intended to identify forward-looking statements.
These statements involve
#Vivos #Therapeutics #VVOS #Earnings #Call #Transcript